Inventiva S.A. Files October 2025 6-K Report
Ticker: IVEVF · Form: 6-K · Filed: Oct 1, 2025 · CIK: 1756594
| Field | Detail |
|---|---|
| Company | Inventiva S.A. (IVEVF) |
| Form Type | 6-K |
| Filed Date | Oct 1, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, reporting
TL;DR
Inventiva S.A. filed its monthly 6-K report for October 2025, confirming its 20-F filing status.
AI Summary
Inventiva S.A. filed a Form 6-K on October 1, 2025, reporting its activities for the month of October 2025. The company, a pharmaceutical preparations firm, is based in Daix, France, and is required to file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Inventiva S.A.'s ongoing operations and compliance with SEC reporting requirements.
Risk Assessment
Risk Level: low — This is a routine periodic filing with no new material financial or operational information disclosed.
Key Players & Entities
- Inventiva S.A. (company) — Registrant
- 001-39374 (company) — SEC File Number
- 20251001 (date) — Filing Date
- October 2025 (date) — Reporting Period
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of October 2025.
Which form does Inventiva S.A. file its annual reports under?
Inventiva S.A. files its annual reports under cover of Form 20-F.
What is the principal executive office address of Inventiva S.A.?
The principal executive offices are located at 50 rue de Dijon, 21121 Daix, France.
What is the Commission File Number for Inventiva S.A.?
The Commission File Number for Inventiva S.A. is 001-39374.
What is the SIC code for Inventiva S.A.?
The Standard Industrial Classification (SIC) code for Inventiva S.A. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 186 words · 1 min read · ~1 pages · Grade level 9.5 · Accepted 2025-10-01 06:05:05
Filing Documents
- f6k_100125.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 16KB
- 0001171843-25-006205.txt ( ) — 22KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inventiva S.A. (Registrant) Date: October 1, 2025 /s/ Frdric Cren Frdric Cren Chief Executive Officer